Webinars

Home » Webinars

RESTORE Trial Webinar – Ask an Integrative Medicine Expert. August 9th 2018

In this webinar, originally broadcast on August 9th 2018, Dr Seema Kanwal and Dr Chris Spooner, naturopathic doctors, discuss their integrative strategies for managing Crohn’s disease and other inflammatory bowel disease (IBD). Dr Shirin Kalyan moderates a panel discussion with these doctors on alternative approaches to IBD.

Webinar – What’s so different about QBECO SSI? Why it’s unlike any other biologic. June 14th 2018

In this webinar, originally broadcast on June 14th 2018, Dr. Shirin. Kalyan and Dr. Mark Bazett outline the science behind Qu’s approach to immune therapy and how it is radically differs from the way current commercially available biologics work.

 

RESTORE clinical trial webinar – Meet the Trial Recruitment nurse and past participants. May 17th 2018

In this webinar, broadcast on May 17th 2018, Qu Biologics’ VP of Clinical Operations Jim Pankovich described Qu’s SSI study outline and technology, and introduced the Clinical Trial Recruitment nurse. We also heard from 2 past clinical trial participants who received QBECO SSI for IBD and described their experiences.

 

QBECO SSI for remission in adults with moderate to severe Crohn’s disease – Trial sites and participation details. April 5th 2018

In this webinar, broadcast on April 5th 2018, Dr. Hal Gunn outlines specifics about Qu Biologics’ latest clinical trial of QBECO SSI for remission in adults with moderate to severe Crohn’s disease. He discusses the study site locations and participation details as well as answering questions posed by the online audience.

 

A study of QBECO SSI for remission in adults with moderate to severe Crohn’s disease. March 5th 2018

In this webinar, first broadcast on March 5th 2018, Dr. Hal Gunn talks about Qu Biologics’ latest clinical trial, testing QBECO SSI for remission in adults with moderate to severe Crohn’s disease. He discusses the study design, participation essentials as well as answering questions posed by the online audience.